MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC
Data sourced from IRS 990 public filings
MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC SUPPORTS CLINICAL TRIALS, DRUG DEVELOP. & RESEARCH RELATING TO TREATMENT & PREVENTION OF MELANOMA.
MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC has received 2 grants from 2 known foundation funders. Revenue decreased from $390,534 in 2019 to $320,000 in 2020. Most recent reported revenue: $375,277.
Annual Revenue
$375,277
Known Funders
2
Grants Received
2
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2020 | $320,000 | $314,821 | $0 |
| 2019 | $390,534 | $379,543 | $558,333 |
| 2018 | $375,277 | $91,055 | $603,844 |
| 2017 | $544,135 | $600,480 | $585,783 |
| 2016 | $224,006 | $242,894 | $305,214 |
| 2015 | $708,867 | $543,146 | $987,202 |
Top Funders
PRINCETON, NJ
PHILADELPHIA, PA
Key Personnel
From 2020 IRS 990 filing
STEVE SILVERSTEIN
CHAIRMAN & PRESIDENT
ANTHONY T HENDRICKSON
TREASURER & CFO
MICHAEL B ATKINS MD
BOARD MEMBER
KEITH T FLAHERTY MD
BOARD MEMBER
JEFFREY E GERSHENWALD MD
BOARD MEMBER
ALISON MARTIN
BOARD MEMBER
ZE'EV RONAI PHD
BOARD MEMBER
Frequently Asked Questions
Other Nonprofits in District of Columbia
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.